Panobinostat sensitizes KRAS‐mutant non‐small‐cell lung cancer to gefitinib by targeting TAZWen‐Ying Lee(Chi Mei Medical Center), Cheng‐Wei Lin(Taipei Medical University)International Journal of CancerJuly 15, 201710.1002/ijc.30888Cited by 44SaveCiteExport RISWatch citationsRelated PapersMetastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit|Theranostics|2019|117Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling|Cells|2020|33